IGNT.PK

[runforthedoor]

  I'm not in IGTN....but most R/S's result in a major PPS drop post split. That is why the PPS fell off a cliff when a R/S was announced. Many people will wait until the post split drop is over before entering this stock. The one thing that can change the post R/S drop is INCREDIBLE news. Some have been daytrading it of late on the bottom here....but there has not been much volume, and I would expect an exit pre split, unless some NEWS makes a difference. That's what you have to weigh here, imho. Hope you do well. 

[gmarc66]

Moving on news that just came in:

2005-11-10 13:15:10 
Ingen Technologies, Inc. 1st Quarter Revenues Exceed $500,000 

CALIMESA, Calif., Nov. 10 /PRNewswire-FirstCall/ -- Ingen Technologies,
Inc. (OTC: IGTN), a medical device manufacturer of OxyAlert(TM), OxyView(TM),
and Secure Balance(TM), announces the SEC Filing for the three months ending
on 08/31/2005.
The Company's auditor's, Spector & Wong, LLP have released the financial
statements for the first quarter from June 1st through August 31st, 2005. The
total revenues generated from Secure Balance(TM) sales were $532,872, and the
Gross Profit was $447,826. The company has invested a total of $6,330,713 in
the research and development of all their medical products, and this
accumulated deficit is expected to decrease now that OxyView(TM) and
OxyAlert(TM) is near completion. The Total Current Assets of the Company have
grown to $442,997, an increase from last year's Total Current Assets of
$9,976. The Cash Balance at the end of the first quarter was $404,432.
"We expect to File the 8-K today, as well as amend the first 10-KSB filed
last week. The following week, our legal counsel will file the other 10-KSB
as scheduled. We are focused on growth, now that the restructuring is behind
us. We have two major trade-shows in December for Secure Balance(TM), and our
RC Engineering has successfully tested the OxyView(TM) prototype, and we are
preparing to build a production model and submit this new product to the FDA
for a 510(k) issuance prior to marketing the device," said Scott Sand, CEO &
Chairman.
About Ingen Technologies, Inc.
Ingen Technologies, Inc. is a public company trading under
NASDAQ OTC: IGTN, which has been in business since 1999. IGTN is a medical
device manufacturer and a growth-oriented company that owns U.S. patent(s),
trademarks, and proprietary medical products.
The Company's flagship product is OxyAlert(TM), a second-generation design
of the Company's BAFI(TM) product line. Both of these products have been
issued two U.S. Patents: Patent No. 6,137,417 issued on October 24, 2000 and
Patent No. 6,326,896 issued on December 4, 2001. Both of these products are
low-oxygen safety warning devices used on remote oxygen cylinders for
patients, commercial aircraft, military transport, and fire and safety
equipment. OxyAlert(TM) technology encompasses the use of digital sensing and
RF frequency transfer so that care givers can access a hand-held remote to
monitor the actual oxygen level of any oxygen cylinder at a reasonable
distance.
The newest product, OxyView(TM), has a patent pending, and is a pneumatic
gauge that provides visual safety warning of oxygen flow to hospitalized
patients. This product enhances the safety, assurance and accuracy of
hospitalized patients being administered oxygen from any source. OxyView(TM)
is a lightweight pneumatic gauge that is attached to the oxygen tubing just
below the neck. It informs the nursing staff of oxygen flow rate near the
patient. It could quickly inform the hospital staff of any leak or inaccuracy
between the delivery source and the patient.
The Secure Balance(TM) product is a private-label product that includes a
vestibular function testing system and balance therapy system. The vestibular
function testing system is manufactured by Interacoustics LTD. in Denmark and
is referred to as the VNG. The balance therapy system is manufactured by
SportKAT(R), Inc. in San Diego, California. The Secure Balance(TM) program
provides equipment, education and training about balance and fall prevention
to physicians and clinicians worldwide.
The Pure Produce(TM) product is a continuing research & development
program currently under design. This program uses hydroponics technology to
grow various plants without the use of soil, fertilizer and water consumption.
The Company anticipates entering the nutriceutical and pharmaceutical markets
over the next two years.
"Our team of professionals has developed our medical products for the
ever-increasing elderly population. Our products are superior to any of our
competition and they allow for effective medical product availability to
seniors, and at the same time the increasing senior population allows for a
steady growth in sales and profits," said Scott Sand, CEO & Chairman of Ingen
Technologies.
For more information, visit www.ingen-tech.com

Investor Relations Contact:

Scott R. Sand, C.E.O & Chairman
Ingen Technologies, Inc. - Administrative Office
35193 Avenue "A", Suite-C
Yucaipa, California 92399
Phone: (800) 259-9622 or (909) 790-7180
Fax: (800) 777-1186 or (909) 795-6340
Email: [email protected]

[setravis]

Form 10KSB for INGEN TECHNOLOGIES, INC.
7-Nov-2005
Annual Report

Limk:  http://biz.yahoo.com/e/051107/igtn.pk10ksb.html

[gmarc66]

2005-11-16 07:15:04 
Ingen Technologies, Inc. Expands Secure Balance Distribution 

CALIMESA, Calif., Nov. 16 /PRNewswire-FirstCall/ -- Ingen Technologies,
Inc. (OTC: IGTN), a medical device manufacturer of OxyAlert(TM), OxyView(TM),
and Secure Balance(TM), announces the strategic exclusive distribution
agreement with Siegel Performance Systems, Inc.
Siegel Performance Systems has been a distributor of fitness and
rehabilitation products for over 25 years, and has provided products for
professional sports, hospitals and clinics throughout the New England area.
Siegel Performance Systems is also known to provide the best service in the
industry with well-trained customer service representatives with high quality;
factory trained certified technicians throughout the country to provide the
most professional service in the industry.
SIEGEL PERFORMANCE SYSTEMS
12 Christa Court
Huntington, NY 11743

Mark Siegel
President
Phone: 631-367-9044
Fax: 631-367-2648
Email: [email protected]
Scott Sand, CEO & Chairman, stated: "We now have a strong distribution rep
group in the New England area that has an established client base and strong
reputation. We will support Siegel Performance Systems with the Secure
Balance(TM) brand of products and services, as well as an affective
advertising campaign."
Siegel Performance Systems has 45 reps that will distribute Secure
Balance(TM) products and services. Secure Balance(TM) offers a complete
approach to the evaluation of balance and fall prevention, offering both the
diagnostic and the rehabilitative tools to help patients regain their balance.
About Ingen Technologies, Inc.
Ingen Technologies, Inc. is a public company trading under
NASDAQ OTC: IGTN, which has been in business since 1999. IGTN is a medical
device manufacturer and a growth-oriented company that owns US patent(s),
trademarks, and proprietary medical products.
The Company's flagship product is OxyAlert(TM), a second-generation design
of the Company's BAFI(TM) product line. Both of these products have been
issued two US Patents: Patent No. 6,137,417 issued on October 24, 2000 and
Patent No. 6,326,896 issued on December 4, 2001. Both of these products are
low-oxygen safety warning devices used on remote oxygen cylinders for
patients, commercial aircraft, military transport, and fire and safety
equipment. OxyAlert(TM) technology encompasses the use of digital sensing and
RF frequency transfer so that care givers can access a hand-held remote to
monitor the actual oxygen level of any oxygen cylinder at a reasonable
distance.
The newest product, OxyView(TM), has a patent pending, and is a pneumatic
gauge that provides visual safety warning of oxygen flow to hospitalized
patients. This product enhances the safety, assurance and accuracy of
hospitalized patients being administered oxygen from any source. OxyView(TM)
is a lightweight pneumatic gauge that is attached to the oxygen tubing just
below the neck. It informs the nursing staff of oxygen flow rate near the
patient. It could quickly inform the hospital staff of any leak or inaccuracy
between the delivery source and the patient.
The Secure Balance(TM) product is a private-label product that includes a
vestibular function testing system and balance therapy system. The vestibular
function testing system is manufactured by Interacoustics LTD. in Denmark and
is referred to as the VNG. The balance therapy system is manufactured by
SportKAT(R), Inc. in San Diego, California. The Secure Balance(TM) program
provides equipment, education and training about balance and fall prevention
to physicians and clinicians worldwide.
The Pure Produce(TM) product is a continuing research & development
program currently under design. This program uses hydroponics technology to
grow various plants without the use of soil, fertilizer and water consumption.
The Company anticipates entering the nutriceutical and pharmaceutical markets
over the next two years.
"Our team of professionals has developed our medical products for the
ever-increasing elderly population. Our products are superior to any of our
competition and they allow for effective medical product availability to
seniors, and at the same time the increasing senior population allows for a
steady growth in sales and profits," said Scott Sand, CEO & Chairman of Ingen
Technologies.

[setravis]

Press Release Source: Ingen Technologies, Inc.


Ingen Technologies, Inc. Receives New Symbol With Reverse Stock Split
Tuesday December 6, 7:15 am ET 
- IGTG: Formerly IGTN -


CALIMESA, Calif., Dec. 6 /PRNewswire-FirstCall/ -- Ingen Technologies, Inc. (OTC: IGTG - News), a medical device manufacturer of OxyAlert(TM), OxyView(TM), and Secure Balance(TM), announces that Stockholders of Ingen Technologies, Inc., a Georgia corporation, voted back on October 31, 2005 for a reverse split of the common stock and Series A Convertible Preferred Stock. The effective date of the reverse split for OTC trading is the opening of business on December 6, 2005. The new trading symbol is IGTG. Under the terms approved by the stockholders, every 40 shares of issued and outstanding common stock shall be converted at the effective time into 1 share of common stock; provided, however, that the corporation shall issue one (1) full share of common stock to its stockholders for any fractional interest remaining after conversion of all outstanding shares.


The corporation's transfer agent is Executive Registrar & Transfer, Inc., 3615 South Huron Street, Suite 104, Englewood, CO 80110, Telephone (303) 783-9055, Facsimile (303) 783-0852. Stockholders who want to exchange their old certificates should contact the transfer agent concerning its procedures and fees.

Further, the symbol change was reported www.otcbb.com/OtherDailyList before the market close on December 5, 2005.

About Ingen Technologies, Inc.

Ingen Technologies, Inc. is a public company trading under NASDAQ OTC: IGTG, which has been in business since 1999. IGTG is a medical device manufacturer and a growth-oriented company that owns US patent(s), trademarks, and proprietary medical products.

The Company's flagship product is OxyAlert(TM), a second-generation design of the Company's BAFI(TM) product line. Both of these products have been issued two US Patents: Patent No. 6,137,417 issued on October 24, 2000 and Patent No. 6,326,896 issued on December 4, 2001. Both of these products are low-oxygen safety warning devices used on remote oxygen cylinders for patients, commercial aircraft, military transport, and fire and safety equipment. OxyAlert(TM) technology encompasses the use of digital sensing and RF frequency transfer so that care givers can access a hand-held remote to monitor the actual oxygen level of any oxygen cylinder at a reasonable distance.

The newest product, OxyView(TM), has a patent pending, and is a pneumatic gauge that provides visual safety warning of oxygen flow to hospitalized patients. This product enhances the safety, assurance and accuracy of hospitalized patients being administered oxygen from any source. OxyView(TM) is a lightweight pneumatic gauge that is attached to the oxygen tubing just below the neck. It informs the nursing staff of oxygen flow rate near the patient. It could quickly inform the hospital staff of any leak or inaccuracy between the delivery source and the patient.

The Secure Balance(TM) product is a private-label product that includes a vestibular function testing system and balance therapy system. The vestibular function testing system is manufactured by Interacoustics LTD. in Denmark and is referred to as the VNG. The balance therapy system is manufactured by SportKAT®, Inc. in San Diego, California. The Secure Balance(TM) program provides equipment, education and training about balance and fall prevention to physicians and clinicians worldwide.

The Pure Produce(TM) product is a continuing research & development program currently under design. This program uses hydroponics technology to grow various plants without the use of soil, fertilizer and water consumption. The Company anticipates entering the nutriceutical and pharmaceutical markets over the next two years.

"Our team of professionals has developed our medical products for the ever-increasing elderly population. Our products are superior to any of our competition and they allow for effective medical product availability to seniors, and at the same time the increasing senior population allows for a steady growth in sales and profits," said Scott Sand, CEO & Chairman of Ingen Technologies.


    For more information, visit www.ingen-tech.com

    Investor Relations Contact:  Scott R. Sand, C.E.O. & Chairman
                                 Ingen Technologies, Inc. - Administrative
                                 Office
                                 35193 Avenue "A", Suite - C
                                 Yucaipa, California 92399
                                 Phone: (800) 259-9622 or (909) 790-7180
                                 Fax: (800) 777-1186 or (909) 795-6340
                                 Email: [email protected]
                                 A Member of the Better Business Bureau
                                 A Member of the Chamber of Commerce
                                 A Licensed Business in the City of Yucaipa

Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements that are made pursuant to "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ will be set forth in the company's periodic filings (the first of which, since reporting ceased in 1998, will be filed shortly) with the U.S. Securities and Exchange Commission.




--------------------------------------------------------------------------------
Source: Ingen Technologies, Inc.

[setravis]

Wow...look at the big volume coming in...
Looks like their reverse split did them in. 

[AussieTrader]

Moving today on results. +125% in early trading 400K shares.

I am holding a small number of  shares in IGTG (7,500) and will continue to hold long term whilst they plan and look to move onto the OTCBB. After the reverse split they now have 11.99M shares outstanding with a market cap just over $2M. Current 6 month revenues are $767K ($1.5M annualized)

Ingen Technologies, Inc. Revenues Increase More Than 300%
PR Newswire - January 13, 2006 07:15
- Gross Profits Increase More Than 400% -


CALIMESA, Calif., Jan 13, 2006 /PRNewswire-FirstCall via COMTEX/ -- Ingen Technologies, Inc. (OTC: IGTG), a medical device manufacturer of OxyAlert(TM), OxyView(TM), and Secure Balance(TM), announces substantial increases in revenues and gross profits.

The revenues for the six months ended November 30, 2005 were $767,084, as compared to the previous year of $223,293. Gross Profits for the six months ended November 30, 2005 were $573,025 as compared to the previous year of $128,046.

The company has invested more than $6,000,000 in the research and development of the product lines, including OxyView(TM) and OxyAlert(TM). During the six months ended November 30, 2005, the company incurred substantial costs to complete OxyView(TM) and continue completion of the OxyAlert(TM) products.

Scott Sand, CEO & Chairman stated: "The revenues for Secure Balance(TM) sales have increased more than 300%, and the Gross Profits have increased even greater. With a focused emphasis on completing all of the SEC Filings, we anticipate a very smooth transition to the OTCBB."

"The reason for the change in retail pricing of the OxyView(TM) was due to the unexpected change in manufacturing costs for OxyView(TM). The current retail pricing of $14.95 is a result of the decrease in manufacturing costs. The company has created a 4+4 Class-A steal mold with special features that have substantially decreased manufacturing costs as compared to the costs published last July-2005 when we released a retail price of $75. This change in retail pricing allows for a more affordable product for hospitals, surgical centers and patients, as well as a higher margin and profit for the company," said Thomas Neavitt, Chief Financial Officer.

[setravis]

Some good news out.....AussieTrader
So now maybe this stock can start to move again.
It's about time !!

Today a White Opening Marubozu was formed. This shows that the day opened and then the prices continued to go up all day long without coming below the opening level thus forming a long white body, however prices did not close at the high of the day and thus they created an upper shadow

The last two candlesticks formed a Bullish Kicking Pattern . This is a bullish reversal pattern that marks a potential change in trend. Though it is highly reliable confirmation is still recommended.

I'm ready to Rock and Roll again......

[setravis]

Here is also a news article that came out on January 03, 2006

*************************************************************

Press Release Source: Ingen Technologies, Inc.


Ingen Technologies, Inc. Introduces OxyView(TM) to Medical Markets
Tuesday January 3, 7:15 am ET 
- Forecasted New Revenues of $14M Per Year for IGTG -


CALIMESA, Calif., Jan. 3 /PRNewswire-FirstCall/ -- Ingen Technologies, Inc. (OTC: IGTG - News), a medical device manufacturer of OxyAlert(TM), OxyView(TM), and Secure Balance(TM), announces that OxyView(TM) is complete and will be ready to be sold to medical markets worldwide in February 2006.


OxyView(TM) is a proprietary medical product with a US Patent Pending that provides a greater certainty of assurance and accuracy of oxygen flow-rate for patients using oxygen during surgery, hospitalization, and outpatient oxygen therapy. OxyView(TM) is a disposable pneumatic analog gauge that accurately measures the oxygen flow-rate close to the patient. It allows the medical staff and patient to quickly determine any malfunction of oxygen flow-rate between the source and the patient. OxyView(TM) can be used with any oxygen delivery source and has additional markets in aviation, fire fighting, and military.

"There are over 5,000 oxygen canula's used everyday in hospitals and surgical rooms, and over 8M patients using oxygen as outpatient therapy for a variety of pulmonary diseases. The hospitals and surgical staff are required to dispose of the units per OSHA regulations. OxyView(TM) is a product that is clean-packaged and disposable," said Chris Wirth, Director of Ingen Technologies.

OxyView(TM) retail pricing will start at $14.95 per unit. With the most current interest in distribution and strategic advertising, the Company anticipates penetrating 10% of the market throughout the year of 2006. This allows for $2.8M sold to hospitals and surgical facilities, and another $12M sold to oxygen suppliers/medical supply chains for patients using outpatient oxygen therapy during the first year. With the enthusiasm and demand the market has displayed towards the OxyView(TM) product, potential sales over the next 3 years could be as much as $40M per year for the Company.

"The elderly population will double and than triple over the next 10 years. The majority of pulmonary diseases reside within our elderly population over 55. OxyView(TM) is available to all patients of any age. With the increasing problems of malpractice law suits, OxyView(TM) provides additional means to assist with the prevention of various medical malpractice issues related to oxygen therapy and provides a means to assure proper and accurate oxygen delivery to all patients. The company provides investors and shareholders increasing revenues proportionate to the increasing demand of our medical products in relation to the growth of our elderly population," said Scott Sand, CEO & Chairman.

The OxyView(TM) information is available on the Company website.

About Ingen Technologies, Inc.

Ingen Technologies, Inc. is a public company trading under NASDAQ OTC:IGTG, which has been in business since 1999. IGTG is a medical device manufacturer and a growth-oriented company that owns US patent(s), trademarks, and proprietary medical products.

The Company's flagship product is OxyAlert(TM), a second-generation design of the Company's BAFI(TM) product line. Both of these products have been issued two US Patents: Patent No. 6,137,417 issued on October 24, 2000 and Patent No. 6,326,896 issued on December 4, 2001. Both of these products are low-oxygen safety warning devices used on remote oxygen cylinders for patients, commercial aircraft, military transport, and fire and safety equipment. OxyAlert(TM) technology encompasses the use of digital sensing and RF frequency transfer so that care givers can access a hand-held remote to monitor the actual oxygen level of any oxygen cylinder at a reasonable distance.

The newest product, OxyView(TM), has a patent pending, and is a pneumatic gauge that provides visual safety warning of oxygen flow to hospitalized patients. This product enhances the safety, assurance and accuracy of hospitalized patients being administered oxygen from any source. OxyView(TM) is a lightweight pneumatic gauge that is attached to the oxygen tubing just below the neck. It informs the nursing staff of oxygen flow rate near the patient. It could quickly inform the hospital staff of any leak or inaccuracy between the delivery source and the patient.

The Secure Balance(TM) product is a private-label product that includes a vestibular function testing system and balance therapy system. The vestibular function testing system is manufactured by Interacoustics LTD. in Denmark and is referred to as the VNG. The balance therapy system is manufactured by SportKAT®, Inc. in San Diego, California. The Secure Balance(TM) program provides equipment, education and training about balance and fall prevention to physicians and clinicians worldwide.

The Pure Produce(TM) product is a continuing research & development program currently under design. This program uses hydroponics technology to grow various plants without the use of soil, fertilizer and water consumption. The Company anticipates entering the nutriceutical and pharmaceutical markets over the next two years.

"Our team of professionals has developed our medical products for the ever-increasing elderly population. Our products are superior to any of our competition and they allow for effective medical product availability to seniors, and at the same time the increasing senior population allows for a steady growth in sales and profits," said Scott Sand, CEO & Chairman of Ingen Technologies.


    For more information, visit www.ingen-tech.com

    Investor Relations Contact:  Scott R. Sand, C.E.O & Chairman
                                 Ingen Technologies, Inc. -
                                 Administrative Office
                                 35193 Avenue "A", Suite-C
                                 Yucaipa, California 92399
                                 Phone: (800) 259-9622 or (909) 790-7180
                                 Fax: (800) 777-1186 or (909) 795-6340
                                 Email: [email protected]
                                 A Member of the Better Business Bureau
                                 A Member of the Chamber of Commerce
                                 A Licensed Business in the City of Yucaipa

Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements that are made pursuant to "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.

--------------------------------------------------------------------------------
Source: Ingen Technologies, Inc.

[setravis]

Maybe we got something going on, up two days in a row.
Back well above the 50-dma.


INGEN TECHNOLOGIES, INC. Files SEC form 10QSB, Quarterly Report
EDGAR Online (Tue 4:58pm)
 
• Ingen Technologies, Inc. Revenues Increase More Than 300%
PR Newswire (Tue 7:15am) 

News Link:  http://finance.yahoo.com/q/h?s=IGTG.PK

[ma7]

 

Press Release

Source: Ingen Technologies, Inc.

Ingen Technologies, Inc. Announces TSI Medical Agrees to Distribute OxyView(TM)
Friday January 20, 7:15 am ET

- IGTG Begins Final Preparation for the OTCBB -

CALIMESA, Calif., Jan. 20 /PRNewswire-FirstCall/ -- Ingen Technologies, Inc. (OTC: IGTG - News), a medical device manufacturer of OxyAlert(TM), OxyView(TM), and Secure Balance(TM), announces that TSI Medical, Ltd. has agreed to distribute OxyView(TM) in North America.


Randal Roberts, President of TSI Medical, Ltd. accepted to finalize a distribution program with Ingen Technologies for the marketing and sale of OxyView(TM). TSI Medical is a leader in selling special instruments in Canada and the United States, with a quality reputation in the physician and hospital markets.

"Randy and I go back almost 10 years in working together with the distribution of medical products with other companies. TSI Medical has very strong distribution channels and connections to place OxyView(TM) in every hospital, nursing home, medical supplier, physician and emergency response facility in North America. Both Randy and I are very excited to create another 'winner' in the medical industry," said Scott Sand, CEO & Chairman of Ingen Technologies.

Corporate attorney, Richard Weed, is now finalizing the schedule to move the company on to the OTCBB. "While attorney Pete Wilke completes the final SEC filings for EDGAR, Mr. Weed will begin the process of filing the documentation needed to complete the move to the OTCBB. This is expected to take 30-60 days, depending on the SEC's satisfaction of the EDGAR filings," said Thomas Neavitt, CFO.

The newest product, OxyView(TM), has a patent pending, and is a pneumatic gauge that provides visual safety warning of oxygen flow for patients in the hospital, surgical room, outpatient therapy, nursing homes and emergency response facilities. This product enhances the safety, assurance and accuracy of patients being administered oxygen from any source. OxyView(TM) is a lightweight pneumatic gauge that is attached to the oxygen tubing just below the neck. It informs the nursing staff of the oxygen flow rate near the patient. It could quickly inform the physician or technician of any leak or inaccuracy between the delivery source and the patient.

[msurad]

I am thinking about getting back in.  I still have a load of shares prior to the R/S.  It looks like a good opportunity to Dollar cost avg this puppy.

[msurad]

Ingen Technologies, Inc. Leading News Agency Reports on Secure Balance(TM)
Thursday February 2, 7:15 am ET 
- 800 Television Stations and 70 Million Viewers -


CALIMESA, Calif., Feb. 2 /PRNewswire-FirstCall/ -- Ingen Technologies, Inc. (OTC: IGTG - News), a medical device manufacturer of OxyAlert(TM), OxyView(TM), and Secure Balance(TM), announces that the company has signed a contract with Max World News to film and develop a news story about the Secure Balance(TM) products for over 800 television stations worldwide.
ADVERTISEMENT


"Rosalind Sedacca, Senior Television News Reporter for Max World News had contacted us after she had learned about our Secure Balance(TM) products and how they have helped thousands of people with balance problems," said Chris Wirth, Director of Ingen Technologies.

The Boynton Beach, Florida based MAX World News is a world-leading newsgathering and delivery service and is recognized as the "one-source" for news delivery. When it comes to producing compelling news stories, their award winning, nationwide network of seasoned television professionals create the impact to get the job done. Max World News has aired stories on every major television network in the United States including, ABC, NBC, CBS, FOX, CNN and CNBC among others and have been seen in over 210 countries around the world, and has personal relationships with health, technology, and consumer interest editors, producers and reporters at every major network in the United States. MAX World News communicates directly with stations to effectively cover breaking news and plan newscasts around observances, seasonal topics and current events.

"This is a very important part of our consumer awareness program. With the "Today's Health" news story about our company being produced next quarter to over 70 million viewers, hospitals and medical professionals; in combination with an unexpected news report being developed by Max World News; our company and the viewers stand to benefit a great deal. Our Secure Balance program can help millions of suffering people, and save billions of dollars spent each year from our Health & Welfare Federal Budget," said Scott Sand, Chairman & CEO of Ingen Technologies.

[setravis]

Oh something is cooking.......

[doug6038]

Setravis, what makes you think something is cooking?